You are here: Industry Insights > drugmakers

News List

Sanofi and other drugmakers stockpile drugs in preparation for Brexit chaos fiercepharma
August 02, 2018
Another drugmaker has confirmed some of its manufacturing facilities are stockpiling key drugs and vaccines as it looks like the U.K. and Europe are barreling toward a head-on collision with Brexit.
Drug companies are indeed looking at ‘substantial’ price cuts, HHS Secretary Azar tells lawmakers fiercepharma
June 14, 2018
President Donald Trump has previously said some drugmakers will announce “voluntary massive drops” in drug prices, and HHS Secretary Alex Azar just assured lawmakers that pharmas are indeed considering “substantial and material” price cuts.
Who can expect the biggest hit under the Senate's budget deal? fiercepharma
February 13, 2018
Pharma will pay more under the new budget deal - and some long-suffering pharmas will pay the most
3 Big Drugmakers With Huge Catalysts on the Horizon biospace
February 01, 2018
Big companies can make big moves, but they don’t necessarily end up making big changes to their stocks.
A Review of the Biggest Big Pharmas, New and Old fiercepharma
August 11, 2017
From perennial giants Johnson & Johnson, Pfizer and Novartis to the buyout targets to the newest names at the top of revenue rankings of pharmaceautical industry, the numbers tell only part of the truths.
Shire targeted by potential buyers in EU, US: report firstwordpharma
July 27, 2017
Some of the largest drugmakers in the EU and US have hired advisers regarding a potential Shire acquisition.
Pfizer, GSK targeted for vaccine pricing in MSF Twitter spree fiercepharma
February 16, 2017
Even after Pfizer and GlaxoSmithKline offered up pneumonia vaccine pricing concessions last fall, Médecins Sans Frontières isn’t letting up in its public pressure campaign against the drugmakers.
Bristol-Myers Squibb Seen as Takeover Bait firstwordpharma
February 15, 2017
People close to the matter revealed that Bristol-Myers Squibb is viewed as a takeover target by multiple drugmakers, StreetInsider reported Tuesday.
Pharma joins Gates Foundation, international governments in $1B outbreak prep group fiercepharma
January 22, 2017
Top drugmakers have joined with governments and nonprofits around the world to launch an alliance that’ll take a proactive approach to potential deadly outbreaks.
Takeda, Ovid to co-develop TAK-935 for paediatric epilepsies firstwordpharma
January 19, 2017
Takeda and Ovid Therapeutics on Wednesday announced a global collaboration to jointly develop and commercialise the Japanese company's experimental selective CH24H inhibitor TAK-935 for the treatment of rare paediatric epilepsies.

Previous page 1 2 Next page